Retension Pharmaceuticals falls 10% during regular tradingMarket Movers·Nov 10, 2026 at 06:45 PMRTSN+0.16%
Retension Pharmaceuticals surges 16% during regular tradingMarket Movers·Nov 9, 2026 at 08:47 PMRTSN+0.16%
Retension Pharmaceuticals to Participate in Fireside Chat at Guggenheim Healthcare Innovation ConferencePUBT·Nov 5, 2026 at 01:10 PMRTSN+0.16%
Retension Pharmaceuticals climbs 9% during regular tradingMarket Movers·Nov 4, 2026 at 03:04 PMRTSN+0.16%
Retension Pharmaceuticals surges 8% during regular tradingMarket Movers·Nov 3, 2026 at 04:24 PMRTSN+0.16%
Retension Pharmaceuticals climbs 10% in regular tradingMarket Movers·Nov 2, 2026 at 02:35 PMRTSN+0.16%
Retension Pharmaceuticals tumbles 8% during regular tradingMarket Movers·Oct 30, 2026 at 01:58 PMRTSN+0.16%
Retension Pharmaceuticals tumbles 9% in regular tradingMarket Movers·Oct 29, 2026 at 03:13 PMRTSN+0.16%
Retension Pharmaceuticals drops 9% in pullback below $13Market Movers·Oct 27, 2026 at 02:10 PMRTSN+0.16%
Retension Pharmaceuticals Names Robert Wong Chief Accounting OfficerPUBT·Oct 23, 2026 at 10:04 AMRTSN+0.16%
Pre-Market Hot Trades in US Stocks: Retension Pharmaceuticals Up 13.59%; Saverone 2014 Down 9.50%Price Alert·Oct 20, 2026 at 10:22 AMRTSN+0.16%SVRE-20.30%
US Stock Market Intraday Update: RTSN Surges 20.11% to Hit ATH; Why Is Capital Rushing In Without Positive Catalysts?Price Alert·Oct 19, 2026 at 03:13 PMRTSN+0.16%
